- Oxford begins first human trial of Bundibugyo Ebola vaccine Mint —
- Oxford University begins human trials of new Ebola vaccine to combat fast-spreading Bundibugyo strain The Independent —
- Oxford begins first human trial of Bundibugyo Ebola vaccine The Straits Times —
- Confirmed Ebola cases in Congo top 1,000, deaths surpass 250, officials say CBS News —
- Ebola cases in Congo surpass 1,000 with 254 people dead, authorities say The Independent —
- Ebola cases top 1,000 in Congo; 254 dead as outbreak spreads Times Of India —
- Red Cross says deadly Congo Ebola epidemic yet to peak, may last a year NY Post —
- Outbreak of rare Ebola strain could become ‘largest on record' as cases hit new high Daily Star —
- Ebola crisis in DR Congo may last a year — Red Cross Punch —
- ‘First line of defence’ against rare Ebola outbreak ‘has collapsed’ Metro —
- Congo expands Ebola testing as outbreak’s real scale eludes officials The Straits Times —
- WHO warns against travel bans as DR Congo battles deadly Ebola outbreak without vaccine Vanguard News —
- Inside the town at the frontline of the Ebola epidemic Sydney Morning Herald —
- Deadly Ebola outbreak spreading 📹 ABC News — · 1min
- Congo traveller tests negative for Ebola in 2nd test The Indian Express —
- As Ebola scourges Congo, experts warn of link to eating wild animals Times Of India —
- WHO chief urges safe burials in visit to heart of Ebola outbreak The Japan Times —
- WHO chief visits Congo in Ebola outbreak The Korea Herald —
- Ebola: FG screens inbound passengers, Hajj returnees Punch —
- WHO chief heads to Ebola epicentre - as Brazil investigates suspected case Sky News —
Bundibugyo ebolavirus
Species of virus
Bundibugyo virus (BDBV) is a species of ebolavirus that is closely related to the Zaire ebolavirus (EBOV). The virus is one of several that can cause Ebola disease in humans, taking the form of viral hemorrhagic fever.
Also known as...
Orthoebolavirus bundibugyoense
Ebola Outbreak Spreads, Vaccine Trials Begin
The Ebola outbreak in DR Congo has spread to five provinces as Oxford begins human trials of a new vaccine.